Filgrastim biosimilar - Claris LifesciencesAlternative Names: Fegrast; Recombinant G-CSF - Claris Lifesciences
Latest Information Update: 01 Oct 2013
At a glance
- Originator Claris Lifesciences
- Class Chemoprotectants; Granulocyte colony-stimulating factors; Neuroprotectants
- Mechanism of Action Granulocyte colony stimulating factor stimulants; Haematopoietic cell growth factor stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Neutropenia
Most Recent Events
- 15 Mar 2016 Biomarkers information updated
- 07 Sep 2012 Launched prior to September 2012 for Neutropenia in India (SC)